EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Natural Compound Melatonin Suppresses Breast Cancer Development by Regulating Circadian Rhythm

Yuanli He, Chenchen Hu, Feiming Hu, Yuanjie Sun, Lin Guo, Junyi Ren, Chenying Han, Yuhui Li, Xiyang Zhang, Yubo Sun, Junqi Zhang, Sirui Cai und 4 weitere

Nutrients · 2025

DOI: 10.3390/nu17213386 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Yuanli He und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Air Force Medical University, No. 169, Changle West Road, Xi'an 710032, China. Hauptthemen laut MEDLINE: Melatonin, Breast Neoplasms, Circadian Rhythm. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, The Young Talent Fund of Association for Science and Technology in Shaanxi, China, Key Laboratory Projects of the Shaanxi Provincial Natural Science Basic Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer remains a major global health threat to women. While current therapies exist, their limitations necessitate novel strategies. Melatonin, an endogenous circadian regulator, has shown anti-tumor potential, but its mechanisms from a circadian perspective require further exploration.

Methods

The anti-tumor effects of melatonin were evaluated through cell proliferation, colony formation, and apoptosis assays. Through data analysis and experimental verification at the RNA and protein levels, the regulatory effect of it on the core clock gene BMAL1 was studied. The role of BMAL1 in mediating melatonin’s suppression of glucose metabolism was assessed by measuring glucose uptake and lactate production. Downstream effector molecules of BMAL1 were identified through molecular interaction and transcriptional regulation analyses.

Results

Melatonin significantly inhibited breast cancer cell proliferation and colony formation and induced apoptosis. Mechanistically, it upregulates the core clock gene BMAL1, which suppresses glucose metabolism. ALDH3A1 was identified as a key downstream target of BMAL1, defining a novel “melatonin-BMAL1-ALDH3A1” axis. In vivo studies confirmed that this axis effectively inhibits tumor growth without apparent toxicity, and SR8278 also shows a synergistic effect when used in combination with melatonin.

Conclusions

Our findings elucidate the role of the “melatonin-BMAL1-ALDH3A1” axis in combating breast cancer, offering a new direction for treatment and laying the groundwork for developing precision chronotherapy-based combination regimens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelatoninBreast NeoplasmsCircadian RhythmFemaleHumansARNTL Transcription FactorsCell ProliferationAnimalsApoptosisCell Line, TumorMiceGlucoseGene Expression Regulation, NeoplasticMCF-7 Cells

Stichwörter der Autor:innen

ALDH3A1BMAL1breast cancercircadian rhythmglycolysismelatonin

Substanzen

MelatoninARNTL Transcription FactorsBMAL1 protein, humanGlucose

Autor:innen und Institutionen

  • Department of Immunology, Air Force Medical University, No. 169, Changle West Road, Xi'an 710032, China.
  • Yan'an Key Laboratory of Microbial Drug Innovation and Transformation, School of Basic Medicine, Yan'an University, Yan'an 716000, China.
  • School of Basic Medicine, Air Force Medical University, No. 169, Changle West Road, Xi'an 710032, China.
  • Military Medical Innovation Center, Air Force Medical University, Xi'an 710032, China.

ORCID-Profile: Dongbo Jiang, Shuya Yang

Förderung

  • National Natural Science Foundation of China
  • The Young Talent Fund of Association for Science and Technology in Shaanxi, China
  • Key Laboratory Projects of the Shaanxi Provincial Natural Science Basic Research Program

Zitieren

APA

He, Y., Hu, C., Hu, F., Sun, Y., Guo, L., Ren, J., Han, C., Li, Y., Zhang, X., Sun, Y., Zhang, J., Cai, S., Wang, Y., Jiang, D., Yang, K., & Yang, S. (2025). Natural Compound Melatonin Suppresses Breast Cancer Development by Regulating Circadian Rhythm. Nutrients. https://doi.org/10.3390/nu17213386

Vancouver

He Y, Hu C, Hu F, Sun Y, Guo L, Ren J, et al. Natural Compound Melatonin Suppresses Breast Cancer Development by Regulating Circadian Rhythm. Nutrients. 2025. doi:10.3390/nu17213386

BibTeX
@article{He2025,
  author = {He, Yuanli and Hu, Chenchen and Hu, Feiming and Sun, Yuanjie and Guo, Lin and Ren, Junyi and Han, Chenying and Li, Yuhui and Zhang, Xiyang and Sun, Yubo and Zhang, Junqi and Cai, Sirui and Wang, Yueyue and Jiang, Dongbo and Yang, Kun and Yang, Shuya},
  title = {Natural Compound Melatonin Suppresses Breast Cancer Development by Regulating Circadian Rhythm},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17213386}
}
Kostenlos starten →